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Regulation of the CCN2 gene by mechanical
forces in smooth muscle cells
Brahim Chaqour, Ru Yang, Quan Sha
SUNY Downstate Medical Center
The CCN2 gene is strongly induced in smooth muscle-rich
hollow organs which experience mechanical overload aris-
ing from either hypertension, altered hemodynamics or
obstruction. This suggests that mechanical forces might be
the primary inducers of the CCN2 gene in smooth muscle
cells. In this study, we found that CCN2 gene expression is
rapidly induced in cyclically stretched bladder smooth
muscle cells (SMCs) in vitro, and in the detrusor muscle
of a mechanically overloaded bladder in a rat model of ex-
perimental urethral obstruction. Molecular analyses of the
CCN2 promoter revealed that a highly conserved NF-κB
binding site located within the CCN2 proximal promoter
region is responsible for the activation of the promoter by
stretch. Chromatin immunoprecipitation assays showed that
NF-κB binds to the endogenous CCN2 promoter in both
stretched cells and mechanically overloaded bladder tissues.
Furthermore, inhibition of either actin polymerization or
actin signaling-dependent pathways significantly altered the
CCN2 promoter activity. Incubation of cultured SMCs with a
cell-penetrating peptide containing the N-terminal sequence,
Ac-EEED, of smooth muscle alpha-actin, altered both actin
cytoskeleton organization and stretch-mediated nuclear
relocation of NF-1B and subsequently, it reduced CCN2
promoter activity. Thus, mechanical stretch-induced changes
in actin dynamics mediate NF-κB activation and induce
CCN2 gene expression.
The 3′-untranslated region-mediated regulation
of the ccn family genes
Satoshi Kubota1, Yoshiki Mukudai2, Harumi Kawaki1,
Masanao Minato1, Takuo Fujisawa1, Yosuke Nakagawa1,
Machiko Honda1, Seiji Kondo1, Masaharu Takigawa1
1Department of Biochemistry and Molecular Dentistry,
Okayama University Graduate School of Medicine, Dentistry
and Pharmaceutical Sciences and 2Biomedical Research
Center, Okayama University Dental School
The 3′-untranslated region (UTR) of the mRNA has been
recently attracting the interest of a number of molecular
biologists, since it contains a variety of post-transcriptional
regulatory elements of gene expression.
Over the years, we have characterized the regulatory
function of the 3′-UTRs of the ccn family genes. In the
3′-UTR of the best-characterized member, ccn2, we already
identified a few post-transcriptional RNA elements that are
critically involved in the regulated ccn2 expression in chon-
drocytes during differentiation. Subsequently, we have been
characterizing the 3′-UTRs of the other members as well.
Interestingly, recent evaluation indicates that the 3′-UTRs of
human ccn1, ccn3, ccn4 and ccn5 are also repressors of gene
expression. Among these 4, the 3′-UTR of ccn4 has been
shown to be involved in the gene induction that is specific in
osteogenic cells. Namely, the repressive effect of the 3′-UTR
is attenuated in human chondrocytic and osteoblastic cells,
which is consistent with the prolonged intracellular half life
and higher steady-state level of the ccn4 mRNA in those cells.
The critical involvement of the 3′-UTRs in the gene regulation
of most members suggests the 3′-UTR as a fundamental
constituent in the ccn family as a part of regulatory machinery.
Expression patterns and phenotypic correlations
of CCN1-3 in an organotypic model
of neurogenesis
Herman Yeger1, Micky Tsui1, Bernard Perbal2
1The Hospital for Sick Children and 2Université Paris 7 D.
Diderot
Expression profiles of the structurally related CCN 1–3
proteins in normal tissues, tumors and cell lines have indicated
differential and dichotomous patterns suggesting functional
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complexity. In order to recapitulate and study complex tissue
organization ex-vivo we are exploring a variety of cell sub-
strata that mimic the 3D extracellular matrix. The multi-
potential NT2 teratocarcinoma model of neurogenesis can
be induced to undergo CNS tissue specific differentiation in
response to inducers like retinoids. NT2 cells were seeded
on UltraWeb, a 3D polyamide synthetic fiber substratum
mimicking extracellular matrix, induced with retinoic acid
(RA), and differentiation followed over time. These cultures
were compared to traditional RA induced NT2 embryoid
bodies plated on a polylysine/laminin substratum and to
uninduced controls. Cultures were immunophenotyped for
expression of CCN 1–3, markers of neuronal, glial and epi-
thelial cell types, and proliferation (BrdU labeling, Ki–67).
UltraWeb cultures showed a remarkable higher degree of
neuronal differentiation and maturation with extensive ax-
onal and dendritic outgrowths. Developing neurons strongly
up-regulated expression of CCN3 correlating with matu-
ration. Mesenchymal phenotypes showed expression of
CCN2. The tissue level organization complexity of Ultra-
Web cultures provides an excellent model to investigate
CCN expression and means to manipulate phenotypes with
biochemical and molecular tools.
CCN2 (connective tissue growth factor) supports
the binding of fibronectin to alpha5beta1
integrin and maintains integrin signaling
Takashi Nishida1, R. Andrea Deyoung2, Harumi Kawaki1,
Masaharu Takigawa1 , Karen M. Lyons2
1Department of Biochemistry and Molecular Dentistry,
Okayama University of Medicine, Dentistry and Pharmaceu-
tical Sciences and 2Department of Orthopaedic Surgery,
Department of Molecular, Cell, and Developmental Biology,
David Geffen School of Medicine at UCLA
The matricellular protein CCN2 (Connective Tissue Growth
Factor; CTGF) is thought to be the major mediator of
excess extracellular matrix (ECM) accumulation in most
fibrotic diseases. A role for CCN2 as an essential mediator
of ECM composition was revealed through analysis of
ccn2 deficient mice. These mice die at birth due to
complications resulting from impaired endochondral ossifi-
cation. However, the mechanism(s) by which CCN2
mediates its effects in cartilage are unclear. We investigated
these mechanisms using chondrocytes isolated from ccn2-
deficient mice. Expression of collagen type II and aggrecan
were decreased in ccn2 mutant chondrocytes, confirming a
defect in ECM production. ccn2-/-chondrocytes also
exhibited impaired DNA synthesis, reduced cartilage
ECM synthesis, and impaired adhesion to fibronectin. This
latter defect is associated with decreased expression of α5
integrin. Moreover, CCN2 acts directly as a ligand for
α5β1 integrin in chondrocytes. Consistent with an essential
role for CCN2 as a ligand for integrins, immunofluores-
cence and Western blot analysis revealed that levels of focal
adhesion kinase (FAK) and extracellular signal-regulated
kinase (ERK)1/2 phosphorylation were reduced in mutant
cells. These findings argue that CCN2 exerts its major
effects in chondrocytes due to its ability to engage integrins
and activate integrin-mediated signaling pathways.
Identification of CCN2/CTGF binding proteins
from human chondrocytes
Takako Hattori1, Daisuke Araki1, Mitsuhiro Hoshijima1,
Eriko Aoyama1, Miho Inoue1, Hiroshi Hanagata2,
Akira Miyauchi3, Masaharu Takigawa1
1Department of Biochemistry & Molecular Dentistry,
Okayama University Graduate School of Medicine, Dentistry
and Pharmaceutical Sciences, Okayama, Japan, 2R & D
Department, Higeta Shoyu Co. Ltd., Choshi, Japan, and
3Choshi Laboratory, ProteinExpress Co. Ltd., Choshi, Japan
To identify CCN2/CTGF interactive proteins which modulate
its action, we carried out a yeast-two hybrid screening using
CCN2 as bait and a cDNA library from the chondrocytic cell
line HCS-2/8, and we found two CCN2-interacting proteins,
fibronectin 1 and matrilin 3. For direct binding to fibronectin1,
only the C-terminal domain (CT) of CCN2 was enough; the
binding enhanced adhesion of HCS-2/8 cells to fibronectin 1
through the integrin receptor α5β1, but did not involve
αvβ3 as shown by blocking with specific antibodies against
integrins. Matrilin-3 is a non-collagenous extracellular
matrix protein, which associates with collagen and plays a
role in collagen fibril assembly. We demonstrated that
CCN2 binds to matrilin-3 in a dose-dependent manner,
and colocalizes with matrilin-3 outside of the cells.
Matrilin-3 supported HCS-2/8 adhesion in a dose depen-
dent manner and CCN2 enhanced HCS-2/8 adhesion to
matrilin-3. An anti-matrilin-3 antibody which inhibits ad-
hesion of HCS-2/8 cells to matrilin-3 did, however, not
inhibit CCN2-enhanced adhesion to matrilin-3. These results
suggest that CCN2 is not only a growth factor, but also a
factor which supports multiple specific interactions with
proteins of the extracellular matrix, cell-matrix interactions,
and the assembly of extracellular matrices.
Notch signal and CCN3 in the bone marrow
derived mesenchymal stem cells
Ken-ichi Katsube
Tokyo Medical and Dental University
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Regulation of bone marrow stem cells (BMSC) seems
rather different from authentic stem cells. To investigate
their property, we focused on Notch signal, one of the
principal systems of stem cells. Notch signal stimulates the
neurogenesis and suppresses the osteogenesis in the BMSC
whereas it suppresses the neurogenesis of neural stem cells
and stimulates the osteogenesis of osteoblasts. One of the
BMSC, called Kusa was chosen for its analyses from its
multipotential property. We examined the downstream of
Notch signal in Kusa by gene chip and found the CCN3
expression dynamically changed depending on the level of
the Notch signal. Previously we reported the Notch signal
activation by CCN3, which implies a positive feedback
between them. Several truncated forms of CCN3 were
introduced expecting a dominant negative or constitutive
active effect. A truncated form of CT domain upregulated
both neurogenesis and osteogenesis of Kusa. We again
performed a gene chip to this transformant and found that
several bHLH transcrition factors are upregulated. Authen-
tic Notch downstream such as Hes family is moderately
upregulated by Notch in Kusa, but other bHLH is
upregulated in this transformant. We are evaluating the
mutual effect of these bHLH factors from the aspect of
CCN3/Notch.
Antiproliferative activity of CCN3-qualitative
and quantitative aspects
Bernard Perbal, Anne Marie Bleau, Noureddine Lazar,
Nathalie Planque
Laboratoire d’Oncologie Virale et Moléculaire, Université
Paris 7, D. Diderot Paris, France
Originally discovered as an integration site of Myeloblastosis
Associated Virus [MAV-1(N)] in avian nephroblastomas, the
ccn3 gene was previously reported to encode a protein with
potential tumor-suppressor activity. In avian nephroblasto-
mas, an elevated expression of ccn3 has been observed, as
compared to the levels of ccn3 expression in normal kidney.
We have shown that the increased expression of ccn3 in
these tumors is related to the differentiated status of the tumor
cells, and established that MAV target cells are blastemal cells
commited to epithelial differentiation. In normal conditions,
the expression of ccn3 is submitted to a tight spatio temporal
regulation and is associated to the differentiation of several
tissues including kidney, bone, and muscle.
In nephroblastoma, proviral MAV integration was
reported to occur within the ccn3 coding sequences and
resulted in the high expression of an aminotruncated CCN3
protein showing transforming properties when assayed on
normal chicken embryo fibroblasts. On the contrary, the
full length CCN3 protein showed an antiproliferative
activity on the same cells. In order to determine whether
the expression of CCN3 was impaired in human tumors,
we have analyzed several different types of tumor cells for
their content and expression of CCN3. We have also used
a series of recombinant plasmids that allow the expression
of CCN3 in transfected cells and tested the ability of
siRNAs to suppress the biological properties of CCN3. In
all the cases that we have studied, the expression of a full
length CCN3 protein suppressed tumor cell growth. Fur-
thermore, similar results were obtained with normal cells,
indicating that the negative activity of CCN3 on cell growth
was not restricted to abnormal situations. The antiprolifer-
ative activity of the CCN3 protein was also demonstrated
by the use of exogenous recombinant proteins and specific
antibodies. Interestingly, in some tumor cells, the elevated
expression of CCN3 was associated to a significant higher
risk of developing metastasis and increased migratory
capacity.
In this communication we will present recent results that
highlight potentials mechanisms that support the negative
role of CCN3 in the regulation of cell proliferation.
Interaction of gap junction protein connexin 43
and CCN3 in breast cancer cells
Wun Chey Sin1, Nathalie Planque2, Bernard Perbal2,
Christian C. Naus1
1University of British Columbia and 2Université Paris 7,
D. Diderot
We have previously shown that overexpression of gap
junction protein Cx43 reverses the oncogenicity of glioma
cells and that enhanced expression of Cx43 facilitates the
redistribution of CCN3 to gap junction plaques containing
Cx43, as well as the secretion of CCN3. We next determine
the role of Cx43 and CCN3 in affecting the oncogenicity of
breast cancer cells. We achieved a reduction of Cx43 in
Hs578T cells by using Cx43 siRNA that resulted in the
translocation of CCN3 from the cytoplasm into the nucleus. In
addition, we observed a decrease in CCN3 expression in
Hs578T-Cx43siRNA cells compared to Hs578T cells trans-
fected with the control vector (Hs578T-control). To determine
whether the C-terminal tail of Cx43 is necessary for CCN3
translocation in breast cancer cells, we overexpressed Cx43t, a
truncated mutant of Cx43 lacking the C-terminal tail known to
interact with CCN3, in Hs578T cells. Hs578T-Cx43t
exhibited a strong nuclear localization of CCN3. In contrast,
overexpression of full length Cx43 in Hs578T cells (Hs578T-
Cx43) results in the absence of CCN3 from the nucleus. Taken
together, these preliminary findings suggest Cx43 is necessary
for both the upregulation and subcellular localization of
CCN3 in breast cancer cells.
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Gap junction protein connexin 43 upregulates
CCN1 in C6 glioma cells
Wun Chey Sin1, Dave C. Bates1, John F. Bechberger1,
Walter J. Rushlow2, Christian C. Naus1
1University of British Columbia and 2University of Western
Ontario
Gap junctions are composed of transmembrane proteins
called connexins. They form channels to allow exchange of
materials between cells and are believed to mediate growth
control by permitting intercellular communication to occur.
Connexin43 (Cx43) is the most abundant gap junction
protein found in astrocytes. As gliomas are transformed
astrocytes with reduced Cx43 expression, we seek to
identify genes that are regulated by Cx43. Here, we report
the overexpression of Cx43 in C6 glioma cells (C6-Cx43)
upregulates the expression of CCN1/Cyr61. Serum stimu-
lation of C6-Cx43, but not parental C6 cells, induced the
expression of CCN1 protein and this enhancement was
maintained for a further 6 hours. We have previously shown
that CCN3/NOV is associated with Cx43 at the gap
junction plaques. In contrast, CCN1 has a diffuse cytoplas-
mic staining without apparent co-localization with Cx43.
Overexpression of CCN1 in C6 glioma cells increased
growth rate of glioma cells under serum-limiting condition.
In contrast, overexpression of Cx43 in glioma cells reduced
growth rate. The dissimilar cellular properties of CCN1 and
Cx43 overexpressors indicate that CCN1 is not the major
mediator of Cx43-dependent growth control.
CTGF/CCN2 inhibits adipocyte differentiation
Stephen M. Twigg, Susan V. McLennan, Paul F. Williams,
Joanne T.M. Tan
Discipline of Medicine, The University of Sydney and
Royal Prince Alfred Hospital, Sydney, Australia
Fat cell differentiation (FCD), or adipogenesis, is impaired in
the metabolic syndrome. TGF beta is known to inhibit FCD
and as CTGF/CCN2 may mediate TGF beta bioactivity, we
determined if CTGF regulates FCD. The 3T3L1 cell line was
differentiated in vitro by IBMX, dexamethasone and insulin.
FCD at d10 was confirmed by measures of key mRNA
markers, PPAR gamma and adiponectin, and also by
triglyceride accumulation (Oil red O) and induced lipogenic
enzyme activity, G3PDH. In parallel wells, cells were treated
repeatedly each 2d of FCD, or by a single treatment on d5,
8 or 10, with either rhCTGF (250 ng/ml) or active rhTGF
beta1 (2 ng/ml). Across 3 independent experiments, both
CTGF and TGF beta1 were found to prevent FCD with ∼30–
50% inhibition of induced PPAR gamma and adiponectin
mRNA (each P < 0.05 by ANOVAwith repeated measures),
and reduced lipid accumulation. We have recently shown that
CTGF is increased in central adipose depots in fat fed mice
compared with subcutaneous sites and also with adipose
depots in standard chow fed animals, further suggesting that
CTGF may impair adipogenesis in vivo. This data collec-
tively indicates that CTGF/CCN2 inhibits fat cell differenti-
ation. The cellular mechanism of this effect is being explored.
Supported by University of Sydney Sesqui grant.
CCN5 suppresses restenosis in a mouse vascular
injury model
Jennifer Malmquist1, Mark Aronovitz2, Michael
Mendelsohn2, Richard Karas2, John Castellot1
1Department of Anatomy and Cell Biology, Tufts Univer-
sity School of Medicine, and 2Molecular Cardiology
Research Institute, Tufts-New England Medical Center,
Boston MA, USA
CCN5 is a growth arrest-specific gene in vascular smooth
muscle cells (VSMC). In culture, growth-arrested VSMC
strongly express CCN5; expression levels decrease during
exponential growth. CCN5 overexpression inhibits VSMC
proliferation, motility, and invasiveness, while knockdown
via siRNA has opposite effects. In vivo, CCN5 expression
dramatically decreases in proliferating VSMCs in a rat
carotid artery balloon vascular injury model. To evaluate
the role of CCN5 in VSMC proliferation in vivo, we
examined its temporospatial expression pattern following a
carotid ligation injury in mice. We measured medial
thickening and neointimal area to evaluate VSMC hyperpla-
sia. Mice were also treated with BrdU to determine cell cycle
status. CCN5 protein expression in injured arteries decreases
dramatically in the media and newly forming neointima, but
increases in the neointima as VSMC proliferation decreases.
We also examined whether CCN5 overexpression via an
adenoviral vector (AdCCN5) protects wild-type mice from
neointimal hyperplasia after carotid ligation injury. AdCCN5
infection strongly suppressed neointimal formation at the
approximate midpoint of the injured section of vessel, while
significant neointima was present in animals infected with
control adenovirus. These data warrant further testing of the
therapeutic potential of CCN5 following vascular surgery.
NIH Grant HL49973
Roles of CCN proteins in skeletal growth
and regeneration
Masaharu Takigawa1, Takuo Fujisawa1,2, Gen Yoshimichi1,
Harumi Kawaki1, Kazumi Kawata1, Takeshi Yanagita1,
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Seiji Kondo1, Yoshiki Mukudai1, Akiko Suzuki3,
Takako Hattori1, Takeyasu Maeda3, Satoshi Kubota1,
Takuo Kuboki2, Bernard Perbal4, Karen M. Lyons5
1Department of Biochemistry and Molecular Dentistry and
2Department of Oral and Maxillofacial Rehabilitation,
Okayama University Graduate School of Medicine and
Dentistry, Okayama, 3Division of Oral Anatomy, Depart-
ment of Oral Biological Science, Niigata University
Graduate School of Medical and Dental Sciences, Niigata,
Japan, 4Laboratoire d’Oncologie Virale et Moléculaire,
UFR de Biochimie, Université Paris, France, 5Department
of Orthopaedic Surgery, David Geffen School of Medicine
at UCLA, Los Angeles, CA, USA
We have shown that CCN2 plays important roles in skeletal
formation and regeneration including endochondral ossifi-
cation. Here we report on new findings in this subject and
the roles of other CCN proteins in chondrocyte differenti-
ation during endochondral ossification.
CCN2 promoted the proliferation and expression of the
differentiated phenotype of auricular chondrocytes in vitro
and cartilage formation in vivo, suggesting that CCN2 plays
important role in development and regeneration of elastic
cartilage, such as auricular cartilage.
PKC was an upstream driver of multiple signal-trans-
ducing kinases including ERK and p38 MAPK that
mediated chondrocyte proliferation and differentiation,
respectively. JNK also mediated CCN2 signals indepen-
dently. Moreover, PI3K transduced CCN2 signals to
promote chondrocyte hypertrophy.
Both in wild-type and the CCN2-mutant mice, the five
CCN members were differentially produced depending
upon chondrocytic differentiation stages. CCN2 deletion
upregulated CCN3 and downregulated CCN6 in cultured
chondrocytes. CCN4 and its variant mRNAs were detected
in growth plate chondrocytes, especially hypertrophic
chondrocytes. Overexpression of CCN4v in chondro-
cytic cells enhanced hypertrophic phenotype. These find-
ings suggest that not only CCN2 but also CCN3, 4 and 6
are involved in terminal differentiation of growth plate
chondrocytes.
Concerning CCN2 signal transduction in cartilage, we
will also report possible role of LRP1.
CCN1 and CCN2 are required for skeletal
and vascular development
Karen Lyons1, Takashi Nishida2, R. Andrea DeYoung1,
Ruth Baxter1, Lisa Dornbach1, Marcos Pacheco3
1University of California, 2641 MacDonald Research
Laboratory and 2Okayama University, Okayama, Japan,
3Universidade Federal do Rio de Janeiro
CCN1/Cyr61 and CCN2/Connective Tissue Growth Factor
are structurally related matricellular proteins with diverse
activities. However, little is known about their roles during
development. We characterized mice carrying null or con-
ditional floxed alleles of ccn1 and ccn2 to address this issue.
Both CCN1 and CCN2 are essential for chondrogenesis,
but have distinct roles. CCN1 is required for joint formation,
whereas CCN2 is essential for formation of the growth plate.
These divergent functions are related in part to distinct patterns
of expression. The effects of CCN2 may be mediated through
effects on expression of multiple integrins. In addition, CCN2
is a ligand for integrins in chondrocytes. In accordance,
ccn2-/-chondrocytes exhibit defects in adhesive signaling.
Analysis of Ccn2 mutants reveals a role for CCN2 in angio-
genesis. Ccn2 mutants exhibit edema, elevated levels of
VEGF, and defects in sprouting angiogenesis. Moreover,
Ccn2fx/fx;VE-CAD mice, lacking CCN2 in developing
vasculature, exhibit early postnatal lethality.
Finally, we examined dermal development in ccn2
mutants. This revealed that the dermal microvasculature is
defective, and that dermal fibroblasts are unable to undergo
contraction in response to TGF beta.
These studies reveal both overlapping and distinct
functions for CCN1 and CCN2 in angiogenesis, dermal
development, and skeletogenesis.
Mechanical stress-related action of NOV (CCN3)
together with periostin in the periodontal
ligament and periosteum
Akira Kudo
Department of Biological Information, Tokyo Institute of
Technology
Periostin is expressed in the periodontal ligament and
periosteum. We generated the periostin deficient-/-mice, and
revealed the disappearance of the shear zone in the periodontal
ligament because of a failure in digestion of collagen fibers,
suggesting that periostin functions in the remodeling of
collagen matrix in the periodontal ligament. In the perioste-
um, mechanical loadings were applied periodically to mouse
tibia. The results showed no observation of an ectopic bone
formation in the periostin-/-mice, indicating that periostin is
essential for mechanical stress-dependent bone formation in
the periosteum. In the molecular analyses, periostin was
associated with the EGF repeats of Notch1, and it enhanced
the Hes1 promoter activity. Furthermore, periostin associated
with CCN3, and this binding site was different from that of
between Notch1 and periositn or CCN3. We also showed that
the interaction of periostin and CCN3 enhanced the Notch
signaling activity, up to 10 fold, in a cooperative manner.
Periostin was co-localized with Notch1 or CCN3 in the
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periodontal ligament and periosteum, however, in the
periostin-/-mice, Notch1 and CCN3 stayed in a cell, suggest-
ing that periostin together with CCN3 functions in transpor-
tation of Notch1 from cytoplasm to cell membrane in the
process of Notch1 activation.
Alveolar bone regeneration using human bone
marrow stromal cells and CCN2
Takuo Kuboki1, Mitsuaki Ono1, Satoshi Kubota2,
Takuo Fujisawa1, Manabu Kanyama1, Wataru Sonoyama1,
Harumi Kawaki2, Kentaro Akiyama1, Masamitsu Oshima1,
Nawachi Kumiko1, Takashi Nishida2, Masaharu Takigawa2
1Department of Oral and Maxillofacial Rehabilitation and
2Department of Biochemistry and Molecular Dentistry,
Okayama University Graduate School of Medicine, Dentistry,
and Pharmaceutical Sciences, Okayama, Japan
Oral implant therapy is a promising prosthetic solutions for
tooth edentulism. However, without enough bone mass, the
modality cannot guarantee its long-term stability and
function. To solve this problem, auto-transplantation of bone
marrow stromal cells (BMSCs), have been studied, without
stable clinical outcome. In the previous study, we found that
CCN2 was expressed strongly in the endothelial cells
migrating into the granulation tissue at the bottom of the
sockets during 4 days after tooth extraction. Thus, CCN2
may play an important role in initiating alveolar bone repair.
In this study, effects of CCN2 on human BMSCs were
examined. To evaluate the effect of CCN2 on cell attach-
ment, we adsorbed CCN2 onto plastic or hydroxyapatite
(HA) plates, and then seeded them with hBMSCs. CCN2-
mediated migration in vitro was evaluated by use of a
modified Boyden chamber method. For estimating the
effect of CCN2 in vivo, we cultured hBMSCs cultured on
porous HA carriers, and then transplanted them subcutane-
ously into immunocompromised mice. Consequently,
CCN2 significantly enhanced the hBMSC attachment, and
this enhancement was negated by the anti-integrin αVβ3
antibody. The migration of hBMSC was also increased
dramatically by CCN2. Moreover, CCN2 accelerated the
hBMSC migration and survival inside the porous HA in
vivo. These results strongly suggest the utility of CCN2 in
alveolar bone regeneration in combination with hBMSCs
and an HA scaffold.
Expression, regulation and function of CCN2
during odontogenesis
Manabu Kanyama1, 2, Hiroki Sugito1, Takuo Kuboki2,
Maurizio Pacifici1, Eiki Koyama1
1Orthopaedic Surgery, Thomas Jefferson University Medical
School, Philadelphia PA, USA 2Oral and Maxillofacial
Rehabilitation, Okayama University Graduate School of
Medicine, Dentistry and Pharmaceutical Sciences, Okayama,
Japan
CCN2 is a potent cytokine which has important roles in
cell differentiation and is believed to mediate epithelial-
mesenchymal interactions in developing organs. Given that
odontogenesis involves similar epithelial–mesenchymal
interactions and cytodifferentiation processes, we asked
whether CCN2 is expressed during mouse tooth develop-
ment, how the expression is regulated, and what roles it may
have. In situ hybridization revealed that CCN2 was present
in epithelial and mesenchymal cells at developmental
periods including bud stage, enamel knot and differentiating
preameloblasts at cap/bell stages; however, the expression
was down-regulated in enamel secreting ameloblasts. Since
these expression patterns were similar to those of BMP-4,
we asked whether BMP-4 may regulate the expression of
CCN2 and found that BMP-4 induced CCN2 in dental
mesenchyme, while BMP antagonist, Noggin, blocked
CCN2 expression. The CCN2 expression started after 1 hr
of BMP-4 treatment and disappeared by 48 hrs. To see the
roles in early odontogenesis, cultured mandibular mesen-
chymal cells were treated with recombinant CCN2. rCCN2
stimulated proliferation of the mesenchymal cells in a dose
dependent manner. Taken together, our data demonstrate
that CCN2 expression is confined to specific sites and times
in the developing tooth germ, is regulated by BMP-4, and
appears to function as a mitogen for early odontogenic
mesenchyme.
Expression of CTGF mRNA and induction
of apoptosis in osteocytes by mechanical
stimulation in mice
Teruko Takano-Yamamoto1, Yuichi Sakai2, Shingo Kuroda2,
Tomohiro Fukunaga2, Nagato Tamamura2,
Masaharu Takigawa3
1Division of Orthodontics and Dentofacial Orthopedics,
Graduate School of Dentistry, Tohoku University, Tohoku,
2Department of Orthodontics and Dentofacial Orthopedics,
Graduate School of Medicine, Dentistry and Pharmaceutical
Sciences, Okayama University, 3Department of Biochemistry
and Molecular Dentistry, Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences, Okayama University,
Okayama, Japan
In the present study, using a mouse experimental tooth
movement model, we investigated the involvement of CTGF
in apoptosis of osteocytes during alveolar bone remodeling
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stimulated by mechanical force. The number of CTGF
mRNA-expressing osteocytes increased maximally at 12
hours from the initiation of tooth movement, and decreased
with time from days 1 to 21. Osteocytes positive on TUNEL
staining, which identifies DNA fragmentation, increased on
the pressure side of the alveolar bone at 12 hours after the
initiation of mechanical stimulation, and then decreased with
time from days 1 to 21. At 12 hours of mechanical stimulation,
many ISOL staining-positive osteocytes were noted on the
pressure side of the alveolar bone, suggesting that the death of
osteocytes was due to apoptosis. On the tension side of the
alveolar bone, no change was noted in the CTGF mRNA
expression level, nor were there increases in the apoptosis-
positive reaction and the number of acellular bone cavities. In
addition, the number of acellular bone cavities markedly
increased on day 3 of mechanical stimulation then decreased
with time from days 7 to 21. After that, the number of
osteoclasts markedly increased on the pressure side of the
alveolar bone on day 7. These findings suggested that CTGF
expressing osteocytes might play a significant role for
triggering bone remodeling and induce osteocyte apoptosis
in the response of bone to mechanical stimulation.
Involvement of CCN1:αvβ3 and CCN1:α6β1
integrin binding in acquisition of antiestrogen
resistance and tumor progression
Ruth Lupu1, Lester Lau2, Hong Liu1, Ingrid Espinoza1
1Evanston Northwestern Healthcare Research Institute,
2University of Illinois Chicago, Northwestern University
Feinberg School of Medicine, IL
The pro-angiogenic regulator CCN1 is overexpressed in
invasive breast cancer cells and tumor biopsies. The ex-
pression of CCN1 is sufficient to promote breast cancer cell
proliferation, cell survival and chemosensitivity through a
αvβ3 integrin-activated ERK1/ERK2 MAPK signaling.
Additionally, CCN1 induces breast cancer cells to bypass
the normal estrogen requirements for growth and acquire an
estrogen-independent and antiestrogen resistant phenotype.
This is apparently mediated via the interaction with the
integrin receptor αvβ3. Here, we investigated whether ex-
pression of CCN1 mutants with substitutions at the αvβ3
(D125A) or α6β1 (TM) binding domains might impede
CCN1’s ability to induce an estrogen (E2)-independent and/
or the antiestrogen resistant phenotype in MCF-7 cells. To
do so, retroviral infection was used to generate MCF-7
stably cell lines expressing either the CCN1-D125A or the
CCN1-TM cDNA variants. Matched controls expressing an
empty pBabe vector were also generated. CCN1 expression
levels were monitored by immunoblotting. To determine
the response of the MCF-7/D125 and MCF-7/TM cells to
estrogen and antiestrogen stimuli we performed a series of
studies in the presence or absence of E2 and in the presence
or absence of the antiestrogens Tamoxifen and ICI 182,782.
Our data demonstrated that mutation of CCN1 at the αvβ3
and α6β1 integrin sites impairs CCN1-induced cell prolif-
eration; the α6β1-binding domain is critical for the CCN1-
triggered signaling that results in a hormone-independent
phenotype in breast cancer cells. Moreover our data dem-
onstrates a differential role for the CCN1 integrin binding
domains in the regulation of the cell proliferation and hormone
response in breast cancer. These results reveal that CCN1
signaling through α6β1 integrin allows the acquisition of an
E2-independent and antiestrogen resistant phenotype in breast
cancer cells. Moreover, cell cycle progression analysis of
MCF-7/D125A and MCF-7/TM cells showed a decreased
proliferative response in comparison to the MCF-7/CCN1
cells as measure by flow cytometric analysis. Collectively,
these data point toward a differential role for the CCN1
integrin binding domains in the regulation of the cell
proliferation and hormone response in breast cancer.
Functional roles of CCN3 in chronic myeloid
leukaemia
Sandra Irvine1, Wanhua Lu1, Susan Price1,
Nathalie Planque2, Nourredine Lazar2, Bernard Perbal2,
Anthony Whetton3, Lynn Mc Callum1
1Queen’s University Belfast, Dept. Haematology Research
and 2Laboratoire d’Oncologie Virale et Moléculaire,
Université Paris 7, D. Diderot, Paris, France, 3Faculty
of Medical and Human Sciences, University of Manchester,
Manchester, UK
Chronic Myeloid Leukemia (CML) is characterized by ex-
pression of the constitutively active BCR-ABL tyrosine
kinase. We have previously identified downregulation of
CCN3 as a consequence of BCR-ABL kinase activity in
human CML cell lines and primary human cells. This study
investigates the functional consequence of expressing CCN3
in BCR-ABL+cells.
CCN3 function was investigated in K562 cells transfected
with vector alone or vector containing a full-length CCN3
construct using flow cytometry and colony formation on
methyl cellulose. CCN3 expression resulted in an accumula-
tion of cells in the subG0 phase of cell cycle (mean for subG0
9.9%±4.6 and 21.8%±0.7 for vector alone and vector
containing CCN3 respectively; n=3, p=0.028). CCN3
expression significantly reduced the clonogenic capacity of
BCR-ABL+cells on methyl cellulose by one third in
comparison to cells transfected with vector alone (n=3, p=
0.027). Cells were then treated with recombinant CCN3
which showed a significant increase in the number of cells in
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the subG0 area (9.3%±3.9 to 23.7%±6.9 for control and
treated cells respectively; n=3, p=0.014).
This study demonstrates CCN3 expression in BCR-ABL+
cells inhibits proliferation and decreases clonogenic potential.
Thus CCN3 down-regulation mediated by BCR-ABL offers
growth advantage to hematopoietic cells.
CCN3 expression is reduced as a result of bcr-abl
kinase in chronic myeloid leukaemia
Lynn McCallum1, Wanhua Lu1, Susan Price1,
Rachel Frazer1, Nathalie Planque2, Bernard Perbal2,
Anthony Whetton3, Alexandra Irvine1
1Queens University Belfast, Dept. Haematology Research
and 2Laboratoire d’Oncologie Virale et Moléculaire,
Université Paris 7, D. Diderot, Paris, France, 3Faculty of
Medical and Human Sciences, University of Manchester,
Manchester, UK
Chronic Myeloid Leukemia (CML) is characterized by
expression of the constitutively active Bcr-Abl tyrosine
kinase. This kinase is associated with downregulation of
CCN3 in human CML cell lines and primary human cells.
The aim of this study was to investigate the relationship
between BCR-ABL and CCN3 expression.
Real-time PCR was used to detect BCR-ABL and CCN3
expression. The CML cell line, K562, showed high BCR-
ABL expression whilst CCN3 was not detected. Treatment
with siRNA directed against BCR-ABL resulted in a 3.7 fold
decrease in BCR-ABL and 6.1 fold increase in CCN3
expression (n=3, p=0.001); treatment with the Bcr-Abl
inhibitor, imatinib, showed a 5.9 fold decrease in BCR-ABL
and 4.2 fold increase in CCN3 (n=3, p=0.001). CCN3
expression was high in normal marrow and blood (range
253–7413 and 120–4280 copies respectively, n=6). BCR-
ABL expression was high in 10 CML patient samples at
diagnosis (range 275–319,000 copies). Patients who
responded to treatment had low CCN3 expression at diagnosis
(range 0–22.1) which increased in response to imatinib
(range 53.6–943); patients who had high levels of CCN3
at diagnosis (range 764–3580) did not achieve molecular
remission.
CCN3 has a reciprocal relationship with BCR-ABL and
provides an additional marker for monitoring clinical
response to imatinib.
Mutational activation of p53 suppresses WISP-2/
CCN5 signaling in breast tumor cells: a novel
circuitry of the progression of cancer
Sushanta Banerjee, Gopal Dhar, Snigdha Banerjee
University of Kansas Medical Center/VA Medical Center
The p53 gene often mutationally activated in human breast
cancer. Its activation is associated with the progression of
cancer. In contrast, WISP-2/CCN5 has been shown to down
regulate in invasive carcinoma cells and tissue samples as
compared to the non-invasive conditions where the expression
is very high. Therefore, we suggest WISP-2/CCN5 deficiency
may be associated with the invasive program. The purpose of
this study is to evaluate whether mutant p53 suppresses WISP-
2/CCN5 expression in breast tumor cells for the progression of
this disease. We found that WISP-2/CCN5 expression is
inversely correlated with the mutational activation of p53 in
breast tumor cells. Moreover, the studies also found that
enforced expression of p53 mutants impaired the expression of
WISP-2/CCN5 in non-invasive breast tumor cells. The genetic
manipulation of mutant p53 changes the behavior of these
cells such as motility. It increased significantly in p53
mediated WISP-2 deficient cells as compared to parent cells
that having constitutive expression of WISP-2/CCN5. This
change can be imitated by blocking the WISP-2 expression
through RNAi or can be reversed by addition of WISP-2
protein in the culture. Collectively, these studies indicate that
WISP-2/CCN5 is a negative regulator of breast cancer
progression from non-invasive to invasive malignancies.
Role and mechanism of connective tissue growth
factor (CCN2/CTGF) induction in osteolytic
metastasis of breast cancer
Tsuyoshi Shimo1, Satoshi Kubota2, Norie Yoshioka1,
Soichiro Ibaragi1, Sachiko Isowa1, Takanori Eguchi2,
Akira Sasaki1, Masaharu Takigawa2
1Department of Oral and Maxillofacial Surgery, and Bio-
pathological Science, Okayama University Graduate School
of Medicine, Dentistry and Pharmaceutical Sciences and
2Department of Biochemistry & Molecular Dentistry,
Okayama University Graduate School of Medicine, Dentistry
and Pharmaceutical Sciences
Connective tissue growth factor (CCN2/CTGF) mediates
angiogenesis induced by breast cancer, but its role in
osteolytic metastasis has not been evaluated. Parathyroid
hormone-related peptide (PTHrP) is another critical factor in
developing osteolytic metastasis. Using both in vivo and in
vitro approaches, we investigated whether/how neutralization
of CCN2 prevented human breast cancer cell line MDA231-
induced bone metastasis, and how PTHrP signaling is related.
Treatment of mice with a CCN2-neutralizing antibody greatly
decreased osteolytic bone metastasis, microvasculature and
osteoclasts involved. The antibody also suppressed the growth
of subcutaneous tumor in vivo and proliferation and
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migration of HUVEC in vitro. Of note, CCN2 expression
was specifically observed in PTHrP/ PTH1R-producing
cancer cells invaded the bone marrow, and PTHrP strongly
upregulated ccn2 in MDA231 cells in vitro. Inhibition of
ERK1/2, PKC or PKA by specific inhibitors counteracted
the stimulation of ccn2 by PTHrP. Consistent with these
findings, inhibition of PKC prevented PTHrP-induced
ERK1/2 activation, while TPA, a stimulator of PKC,
upregulated it. In conclusion, CCN2 was critically involved
in osteolytic metastasis and was induced by PKA and PKC-
dependent activation of ERK1/2 signaling by PTHrP. Thus,
N2 may be a new molecular target for anti-osteolytic therapy
to shut off the PTHrP-CCN2 signaling pathway.
High expression of connective tissue growth factor
in paediatric pre-b acute lymphoblastic leukaemia
Joanne M. Boag1, Alex H. Beesley1, Martin J. Firth2,
Joseph R. Freitas1, Jette Ford1, David R. Brigstock3,
Nicholas H. de Klerk2, Ursula R. Kees1
1Division of Children’s Leukaemia and Cancer Research,
and 2Division of Biostatistics and Genetic Epidemiology,
Telethon Institute for Child Health Research, and Centre for
Child Health Research, The University of Western Australia,
Perth, Western Australia. 3Pediatric Surgery Research Labo-
ratory, Children’s Research Institute, Columbus, Ohio, USA
Gene expression studies have provided new insights into
paediatric acute lymphoblastic leukaemia (ALL). Few
studies, however, have analysed normal haematopoietic
cell populations to identify altered gene expression in ALL.
We used oligonucleotide microarrays to compare the gene
expression profile of paediatric precursor B (pre-B) ALL
specimens with two control cell populations, normal
CD34+and CD19+/IgM−cells, in order to focus on genes
linked to leukaemogenesis. We identified eight highly
deregulated genes, all showing ≥9-fold higher average
expression in ALL specimens compared to control cells.
These genes were confirmed as significantly deregulated
in an independent cohort of 101 ALL specimens. One
gene, connective tissue growth factor (CTGF/CCN2), had
exceptionally high expression, and this was confirmed in
three independent leukaemia studies. Further analysis of
CTGF expression in ALL revealed exclusive expression in
B-lineage, not T-lineage ALL. Within B-lineage ALL ap-
proximately 75% of specimens were consistently positive
for CTGF expression, however, specimens containing the
E2A-PBX1 translocation showed low or no expression.
Protein studies by Western blot analysis demonstrated the
presence of CTGF in supernatants of ALL cells. These
findings indicate that CTGF is secreted by pre-B ALL cells
and may play a role in the pathophysiology of this disease.
Role of the ccn family (CCN1, CCN2) in glomer-
ular remodeling and renal disease
Masashi Mukoyama, Hideki Yokoi, Kazutomo Sawai,
Kazuwa Nakao
Department of Medicine and Clinical Science, Kyoto
University Graduate School of Medicine
The CCN family proteins are essential for angiogenesis and
chondrogenesis, but their role in renal pathophysiology
remains unknown. During glomerular remodeling, factors
produced by glomerular podocytes may be critically in-
volved. We therefore screened for genes that are expressed
in podocytes and are upregulated in anti-Thy-1 glomerulo-
nephritis, a reversible nephropathy model. Using suppres-
sion subtractive hybridization, we identified CCN1 among
40 such genes obtained. CCN1 was upregulated specifically
at podocytes in early regeneration stages. Recombinant
CCN1 enhanced endothelial cell adhesion, but strongly
inhibited mesangial cell adhesion and migration. CCN1
also induced podocyte-specific genes, suggesting CCN1 as
a podocyte differentiation factor and a mesangial-repellent
factor, involved in glomerular remodeling.
CCN2, on the other hand, is a crucial mediator of
tubulointerstitial fibrosis, a final common pathway of various
nephropathies. We already revealed that CCN2 is a down-
stream mediator of fibrogenic property of TGF-β. Antisense
knockdown of CCN2 in the kidney markedly ameliorated
interstitial fibrosis and epithelial-mesenchymal transforma-
tion. Furthermore, we generated transgenic mice having
podocyte-specific expression of CCN2, which revealed
deterioration of glomerular injury. Thus, CCN2 may become
a possible target against renal injury progression. Taken
together, the CCN family may have a dual modulatory role
in renal diseases, i.e., renoprotection and disease progression.
The effects of aminoguanidine on CCN-family
member gene expression in the diabetic rat retina
Ingeborg Klaassen1, John M. Hughes1, Esther J. Kuiper1,
Paul Canning2, Alan W. Stitt2, Jan van Bezu3,
Casper G. Schalkwijk3, Reinier O. Schlingemann1
1Department of Ophthalmology, Academic Medical Center,
University of Amsterdam, Amsterdam, The Netherlands,
2Department of Ophthalmology, The Queen’s University of
Belfast, The Royal Victoria Hospital, Belfast, Northern
Ireland, UK., 3Department of Clinical Chemistry and Institute
of Cardiovascular Research, VU University Medical Center,
Amsterdam, The Netherlands
The CCN growth factors (Cyr61, CTGF, Nov and WISP-1,-
2 and -3) affect cellular growth, differentiation, adhesion
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and locomotion in wound repair, fibrotic disorders, inflam-
mation and angiogenesis. Advanced glycation endproducts
(AGEs) formed in the diabetic milieu affect the same
processes, leading to diabetic complications including
diabetic retinopathy. We hypothesize that the pathological
effects of AGEs in the diabetic retina are a consequence of
AGE-induced alterations in CCN family expression.
Methods: CCN gene expression levels were studied in
retinas of control and diabetic rats using real-time quanti-
tative PCR (qPCR) at 6 and 12 weeks of streptozotocin-
induced diabetes, with or without aminoguanidine to study
the effects of inhibition of endogenous AGE formation.
Results: After 6 weeks of diabetes, Cyr61 was upregulated
more than 3-fold. At 12 weeks of diabetes, CTGF was
upregulated 1.9-fold. Aminoguanidine treatment signifi-
cantly reduced the Cyr61 and CTGF expression in diabetic
rats by 1.5-fold and 1.8-fold, respectively. Immunoblotting
for CTGF confirmed these results demonstrating a 1.8-fold
increase in protein expression which was abrogated by
aminoguanidine treatment.
Conclusions: CTGF and Cyr61 are downstream effectors of
AGEs in the diabetic retina, implicating them as possible
targets for future intervention strategies against the devel-
opment of diabetic retinopathy.
Neutralizing antibody to human connective tissue
growth factor ameliorates transforming growth
factor-beta-induced mouse fibrosis model
Poh-Sing NG1, Koki Endo1, Norihisa Otake1, Megumi
Iijima1, Tomohiro Mori1, Yuka Ikawa2, Miki Kondo2, Sonoko
Chujyo2, Kazuhiko Takehara2
1Nosan Corporation and 2Grad Sch Med Sci, Kanazawa Univ.
Purpose: Skin fibrotic disorders such as systemic sclerosis
(SSc) are characterized by an excessive production of
extracellular matrix, and are considered to develop under the
influence of certain growth factors. To better understand the
mechanisms of persistent fibrosis in SSc, we have investi-
gated whether anti-CTGF neutralizing antibody ameliorates
skin fibrosis in our skin fibrosis animal model, which was
induced by exogenous TGF beta.
Methods: We developed monoclonal antibodies against the
native structure of human CTGF using DNA immunization
methods. Subsequently, newborn mice received subcutane-
ous injections of TGF-beta for 3 days with either anti-
CTGF neutralizing antibodies or control purified mouse
immunoglobulin. The fibrosis observed in our animal
model on day 4 was evaluated by the H-E staining.
Results: We established monoclonal antibodies recognizing
the native conformation of human CTGF. Among them,
neutralizing antibody to module 1 and module 2 signifi-
cantly reduced skin fibrosis in our mice model.
Conclusions: Our results indicated that CTGF monoclo-
nal antibody inhibited the fibrosis formation by blocking
the TGF beta induced endogenous CTGF of mouse. The
result suggests that anti-CTGF neutralizing antibodies
are a feasible strategy to treat skin fibrotic diseases.
Especially, module 1 and module 2 may be an efficient
target of CTGF.
A profibrotic role of CCN2 in the progressive
kidney diseases
Hirokazu Okada, Tsutomu Inoue, Hiromichi Suzuki
Department of Nephrology, Saitama Medical School
CCN2 is a down-stream mediator of TGF-β, which is a key
growth factor involved in renal fibrogenesis, and as such
plays a unique role in mediating mesangial cell/fibroblast
proliferation and extracellular matrix production by renal
cells. Podocytes, mesangial cells, fibroblasts and endothelial
cells produce CCN2 in fibrosing kidneys. We showed that
tubular epithelial cells also produced CCN2, which played
an essential role in renal fibrogenesis in the murine remnant
kidney model and human diabetic nephropathy. Similar to
the other cells, an important inducer of CCN2 in epithelial
cells is TGF-β. Recently, in addition to BCE-1 and SBE sites
in the ccn2 gene promoter that are responsible for TGF-β
induction of CCN2 in fibroblasts, we identified a novel,
TGF-β-responsive, cis-regulatory element specifically ac-
tive in the tubular epithelial cells. In my presentation, I will
summarize how CCN2 involves in the pathogenesis of
progressive kidney diseases and how ccn2 gene expression
is regulated in the tubular epithelial cells mainly through
data coming up from my laboratory, and mention a
possibility of future application for anti-fibrotic therapies.
against renal fibrogenesis, a common feature of the
progressive kidney diseases.
Overexpression of CCN2 in podocytes deteriorates
diabetic nephropathy in diabetic mice
Hideki Yokoi1, Masashi Mukoyama1, Kiyoshi Mori1,
Masato Kasahara1, Kazutomo Sawai1, Takayoshi Suganami1,
Masao Koshikawa1, Tetsuro Yoshioka1, Yoko Saito1,
Akira Sugawara2, Kazuwa Nakao1
1Kyoto University Graduate School of Medicine, Department
of Medicine and Clinical Science and 2National Hospital
Organization Kyoto Medical Center, Division of Nephrology
CCN2 is a key mediator of fibrogenic properties of TGF-β.
CCN2 mRNA is upregulated in the glomeruli in diabetic
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nephropathy and CCN2 is thought to be involved in the
progression of diabetic nephropathy. To elucidate the role of
CCN2 upregulation in podocytes on diabetic nephropathy,
we generated transgenic mice (Tg) harboring the mouse
CCN2 gene under regulation of human nephrin promoter
that is capable of directing podocyte-specific expression.
CCN2-Tg had no apparent renal abnormalities at basal
conditions. Then, we investigated the progression of renal
injury in diabetic CCN2-Tg induced by streptozotocin for 12
weeks. After induction of diabetes, CCN2-Tg exhibited
significantly increased urinary albumin excretion by 2.8-fold
( p < 0.01) compared with WT. Diabetic CCN2-Tg showed
increased mesangial expansion and reduced number of
podocytes and enhanced vacuolar formation in podocytes
by electron microscopic analysis. Immunohistochemical
study for podocin revealed disarranged podocin expression
in diabetic CCN2-Tg. These results indicate that the
overexpression of CCN2 in podocytes can accelerate
deterioration of glomerular injuries under diabetic milieu,
suggesting that CCN2 plays an important role in the
progression of diabetic nephropathy.
Connective tissue growth factor induces
myocardial fibrosis, but preserves myocardial
function in pressure-induced
myocardial hypertrophy
Muhammad Shakil Ahmed1, Thomas von Luedera1,
Jorgen Gravning1, Thor Edvardsen1, Erik Oie2,
Birthe Mikkelsen1, Leif Erik Vinge1, Otto Smiseth2,
Havard Attramada1
1Institute for Surgical Research, Rikshospitalet University
Hospital, and Faculty Division Rikshospitalet, University of
Oslo, Oslo, Norway and 2Dept. of Cardiology, Rikshospitalet
University Hospital, and Faculty Division Rikshospitalet,
University of Oslo, Oslo, Norway
Induction of connective tissue growth factor (CTGF) has been
demonstrated in heart failure. Yet, the pathophysiologic
significance of myocardial CTGF in heart failure remains to
be resolved. To elucidate the function of CTGF in the heart,
we generated transgenic mice (Tg-CTGF) with cardiac-
specific overexpression. Left ventricular end-diastolic pres-
sure (LVEDP) was significantly elevated in Tg-CTGF mice
with reduced ventricular compliance. Analysis of myocardial
hydroxyproline contents by quantitative HPLC revealed
increased myocardial collagen in Tg-CTGF vs. NLC hearts
(1.10 ± 0.03 vs.0.82 ± 0.05 pmol/mg; p<0.05). Consistently,
increased myocardial collagen (I) and (III) mRNA levels were
found in Tg-CTGF hearts (9.4 ± 0.8 vs. 6.6 ± 0.2 and 8.6 ± 0.5
vs. 5.0 ± 0.1, respectively; p<0.05). Pressure overload was
induced by abdominal aortic banding (AB) in weight-
matched male transgenic (CTGF-AB) and non-transgenic
mice (NLC-AB). Four weeks after aortic banding, NLC-AB
mice displayed overt evidence of cardiac dysfunction. NLC-
AB mice displayed significantly increased left ventricular
end-diastolic diameter (LVEDD) and LVEDP, and decreased
fractional shortening, dP/dtmax, and stroke volume as
compared with NLC-sham. Conversely, CTGF-AB mice
displayed preserved left ventricular pressure-volume rela-
tions. Myocardial CTGF causes interstitial fibrosis with
subtle indices of restrictive cardiac dysfunction, but rescues
left ventricular function during pressure overload.
The role of CCN2 in the development of cardiac
fibrosis and its clinical utility for the diagnosis
of heart failure
Masashi Arai1, Norimichi Koitabashi1, Kazuo Niwano1,
Atai Watanabe1, Takashi Nishida2, Satoshi Kubota2,
Masaharu Takigawa2, Masahiko Kurabayashi1
1Department of Medicine and Biological Science, Gunma
University Graduate School of Medicine and 2Department of
Biochemistry and Molecular Dentistry, Okayama University
Graduate School of Medicine, Dentistry and Pharmaceutical
Sciences
Purpose: The present study was intended to clarify the role
of CCN2 and its functional interactions with brain natriuretic
peptide (BNP), an anti-fibrotic peptide, on the development
of myocardial fibrosis and diastolic heart failure.
Results: In rat pressure-overload cardiac hypertrophy
model, relative abundance of mRNA for CCN2 to BNP
was correlated with left ventricular stiffness (r=0.720, P=
0.001), myocardial fibrosis area (r=0.608, P=0.002), and
procollagen 1 mRNA expression (r=0.488, P=0.001). Rats
with higher CCN2/BNP ratio had a higher plasma aldoste-
rone concentration. Further investigation demonstrated that
CCN2 secreted by cardiac myocytes induced collagen
production in cardiac fibroblasts. G-protein coupled recep-
tor ligands induced CCN2 and BNP mRNAs comparably,
while aldosterone and TGF-beta preferentially induced
expression of CCN2 mRNA. Endomyocardial biopsy from
patient with diastolic dysfunction revealed that the abun-
dance of CCN2-positive myocytes was referred to the ex-
cessive interstitial fibrosis (N=46, r=0.638, P=0.001) and
the acute pulmonary congestion. Plasma CCN2 concentra-
tion was significantly elevated in symptomatic patients and
correlated with plasma BNP (r=0.395, P=0.01).
Conclusion: The disproportionate increase in CCN2 relative
to BNP in cardiac myocytes plays a central role in the in-
duction of excessive myocardial fibrosis and diastolic heart
failure. Furthermore, CCN2 may serve as a novel diagnos-
tic modality for heart failure.
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Comparison of patterns of expression of CCN5
and CCN2 in rodent tissues
Mark R. Gray1, Jennifer Malmquist1, Michael Blea1,
John J. Castellot, Jr1,2
1Department of Anatomy and Cell Biology; 2Department
of Pharmacology and Experimental Therapeutics; Tufts
University School of Medicine, Boston MA, USA
CCN5 is a secreted heparin-and estrogen-regulated matri-
cellular protein that can inhibit vertebrate smooth muscle cell
proliferation and motility. CCN5 is expressed throughout
murine and human embryonic development in most organs
and tissues. This ubiquitous embryonic expression of CCN5
might be a consequence of the hyper-estrogenic intrauterine
environment. However, after embryonic development is
complete, we expected that CCN5 distribution would be
largely restricted to small set of tissues, including smooth
muscle cells of the arteries, uterus, airway, and digestive
tract. Because CCN5 inhibits proliferation of smooth muscle
cells in vitro, it might be necessary to prevent excessive
growth in vivo. In contrast, another member of the CCN
family, CCN2, promotes smooth muscle cell proliferation in
vitro and thus it is expected that its expression levels would
be low in uninjured normal adult tissues. Frozen sections
from adult tissues and organs were analyzed by immuno-
histochemistry using anti-CCN5 and anti-CCN2 antibodies.
Both CCN5 and CCN2 expression was detected ubiqui-
tously, in the aorta, uterus, bronchioles, and digestive tract
as expected, and also in many other adult tissues including
the pancreas, spleen, stomach skeletal muscle, ovary, testis,
thymus, brain, olfactory epithelium, and kidney. CCN5 and
CCN2 expression was found in smooth muscle, endothelial
cells, epithelial cells, epithelial cells, skeletal muscle, cells
of the nervous system, and numerous other cell types.
Rather than having opposite patterns of expression, CCN5
and CCN2 had similar and largely overlapping sites of
expression. The wide distribution of both CCN5 and CCN2
suggests that both proteins have additional biological
functions beyond those identified in specific cellular and
disease models.
Functional analysis of a transgenic mouse
expressing reduced levels of CCN5
in an inducible, tissue-specific manner
Michael Blea, John Castellot
Program in Cell, Molecular and Developmental Biology,
Tufts University School of Medicine, Boston MA, USA
Hyperproliferation of smooth muscle cells (SMC) is the hall-
mark of many important diseases, including arterial restenosis
and uterine fibroids. Our examination of agents that could
suppress SMC proliferation led to the discovery of CCN5, a
heparin-and estrogen-induced gene and protein that strongly
inhibits SMC proliferation and motility. To further investigate
the role of CCN5 in SMC, a mouse with substantially reduced
expression of CCN5 (<25% normal) will be generated by the
inducible expression of short hairpin RNA (shRNA) under the
control of a tetracycline on/off system. Tissue-specific
expression will be achieved using SMC-specific promoters
such as SM-22, SMC myosin and a uterine specific promoter.
We hypothesize that reduced levels of CCN5 will exacerbate
SMC hyperproliferation in mouse models for vascular injury.
Supporting this notion is our recent demonstration in mouse,
rat and human SMC cell cultures that a short interfering RNA
(siRNA) directed against CCN5 strongly inhibits SMC
proliferation and motility. Our strategy requires generating
two mice, which will then be crossed to produce a functional
knockdown of CCN5 that is both inducible and tissue-
specific. This approach may also prove useful in generating
functional transgenic knockdowns of other proteins in an
inducible and tissue-specific manner.
NIH Grant HL49973 and NIH Grant HD046251
Possibility of auricular cartilage reconstruction
with CCN2/CTGF
Takuo Fujisawa1, Kyoji Nakao2, Mitsuaki Ono1,
Takako Hattori2, Satoshi Kubota2, Takuo Kuboki1,
Masaharu Takigawa2
1Okayama University Graduate School of Medicine, Dentistry
and Pharmaceutical Sciences, Department of Oral and
Maxillofacial Rehabilitation and 2Okayama University Graduate
School of Medicine, Dentistry and Pharmaceutical Sciences,
Department of Biochemistry and Molecular Dentistry
Our previous study indicated that CCN2/CTGF might
reinforce their own molecular phenotype of chondrocytes
derived from different cartilage, such as growth cartilage
and articular cartilage. Therefore, in this study, we tried to
investigate the effects of CCN2 on auricular chondrocytes
proliferation, matrix synthesis, gene expression of differen-
tiated markers and in vivo cartilage formation. Rabbit
primary auricular chondrocytes were cultured in the
presence or absence of various concen-tration of recombi-
nant human CCN2. The cell proliferation was evaluated by
MTS assay and [3H]-thymidine incorporation, and the
proteoglycan synthesis was determined by [35S]-sulfate
incorporation. The mRNA levels of chondrocyte differen-
tiation markers were evaluated by real-time RT-PCR, and
the accumulation of elastin fibers were visualized by
Victoria-blue stain. Cartilage formation was evaluated by
in vivo implantation of chondrocytes pellets.
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CCN2 stimulated the cell proliferation, DNA synthesis and
proteoglycan synthesis. The gene expression of elastin and col 2
were also increased. In addition, the accumulation of elastin
fiber was up-regulated. Finally, in vivo implantation experiment
indicated that CCN2 strongly accelerated cartilage formation.
This is the first report to show that CCN2 promotes the
phenotypes of the auricular chondrocytes, which suggests
that CCN2 may be useful for repair or reconstruction of
elastic cartilage, e.g., auricular cartilage.
CT domain of CCN2/CTGF directly interacts
with fibronectin and enhances cell adhesion
of chondrocytes through integrin alpha 5 beta 1
Takako Hattori1, Mitsuhiro Hoshijima1, Eriko Aoyama1,
Miho Inoue1, Daisuke Araki1, Hiroshi Hanagata2,
Akira Miyauchi3, Masaharu Takigawa1
1Department of Biochemistry & Molecular Dentistry,
Okayama University Graduate School of Medicine, Dentistry
and Pharmaceutical Sciences and 2R & D Department, Higeta
Shoyu Co. Ltd., 3Choshi Laboratory, ProteinExpress Co. Ltd.
CCN2/CTGF is strongly expressed in cartilage, especially in
hypertrophic chondrocytes; it modulates chondrocyte differ-
entiation and proliferation and enhances production of
extracellular matrices, cell adhesion andmigration. To identify
CCN2/CTGF interactive proteins which modulate its action,
we carried out yeast-two hybrid screening using a cDNA
library from the chondrocytic cell line HCS-2/8 and CCN2 as
bait. One of the proteins interacting with CCN2/CTGF was
fibronectin 1. In the yeast two-hybrid assay we found that only
the C-terminal domain (CT) of CCN2/CTGF binds directly to
fibronectin 1; the binding enhances adhesion of HCS-2/8 cells
to fibronectin 1 in a dose-dependent manner. The same
domain has been shown by others to bind to the fibronectin
receptors alpha5beta1 and alphavbeta3. A monoclonal anti-
body against the CT domain partially inhibited CCN2/CTGF
adhesion activity, indicating that CCN2/CTGF enhances
integrin mediated cell adhesion to fibronectin through its CT
domain. CCN2/CTGF enhanced chondrocyte adhesion to
fibronectin was abolished by a blocking antibody against
alpha5beta1, but not by anti alphavbeta3. These findings
suggest that CCN2/CTGF may be trapped by fibronectin 1 in
the extracellular matrix and enhances fibronectin binding
through the integrin receptor alpha5beta1, but not to alphav-
beta3, thereby enhancing alpha5beta1- mediated activation
and cell adhesion of chondrocytes.
Effect of CCN2 deletion on the expression
of the other ccn family members
during chondrocytic terminal differentiation
Harumi Kawaki1, Satoshi Kubota1, Akiko Suzuki2,
Bernard Perbal3, Takeyasu Maeda2, Karen M. Lyons4,
Masaharu Takigawa1
1Department of Biochemistry and Molecular Dentistry,
Okayama University Graduate School of Medicine, Dentistry,
and Pharmaceutial Sciences and 2Division of Oral Anatomy,
Department of Oral Biological Science, Niigata University
Graduate School of Medical and Dental Sciences,
3Laboratoire d’Oncologie Virale et Moléculaire, UFR de
Biochimie, Université Paris 7, D. Diderot, 4Department of
Orthopaedic Surgery, David Geffen School of Medicine at
UCLA, University of California
Among the CCN family members, CCN2 is known as an
important regulator in the endochondral ossification, as
represented by the disorganized hypertrophic zone in the
growth plate of CCN2-mutant mice. In this study, we
investigated on the other CCN members during chondrocytic
terminal differentiation. Initially, distribution of the other CCN
members in developing growth plate cartilage was analyzed.
The five CCN members were differentially produced depend-
ing upon chondrocytic differentiation stages both in wild-type
and the CCN2-mutant mice, although hypertrophic and
prehypertrophic zones were enlarged in the CCN2-mutant.
Next, we isolated chondrocytes from both mice and induced
their differentiation in culture. In the CCN2-mutant chondro-
cytes, mRNAs of chondrocyte markers showed less increase
than in wild-type upon terminal differentiation, and calcifica-
tion was delayed. Concerning the other five CCN members,
CCN2 deletion caused upregulation of CCN3 and down-
regulation of CCN6 under regular culture conditions. Along
with differentiation, the CCN6 mRNA in the CCN2-mutant
chondrocytes did not show the increase that was observed in
wild-type chondrocytes. In contract, CCN3 expression
showed more striking increase in the CCN2-mutant chondro-
cytes than the wild-type. These results suggest possible role of
CCN3 and 6 in the chondrocytic terminal differentiation in
collaboration with CCN2.
Expression and possible function of a CCN2
receptor, low density lipoprotein receptor-
related protein 1 (LRP1), in chondrocytes
Kazumi Kawata1, Satoshi Kubota1, Takanori Eguchi1,
Harumi Kawaki1, Morihiko Oka2, Shogo Minagi2,
Masaharu Takigawa1
1Department of Biochemistry and Molecular Dentistry,
Okayama University Graduate School of Medicine, Den-
tistry and Pharmaceutical Sciences and 2Department of
Occlusal and Oral Functional Rehabilitation, Okayama
University Graduate School of Medicine, Dentistry and
Pharmaceutical Sciences
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LRP1 has been known as an endocytic and signal transmission
receptor. LRP1 binds to various ligands, including CCN2,
which is a critical factor in endochondral ossification and
cartilage regeneration. However, expression and function of
LRP1 in normal chondrocytes remains to be investigated. We
formerly reported the gene expression and the localization of
LRP1 in cartilage and chondrocytes. In the present study, we
describe the endocytotic incorporation of CCN2 into chon-
drocytes and possible roles of LRP1 therein.
Co-localization of endogenous CCN2 and LRP1 was
observed on the surface and in the cytoplasm of HCS-2/8. To
investigate internalization of CCN2 in chondrocytes, we
exogenously added Cy3-labeled recombinant CCN2
(rCCN2) to HCS-2/8 and chased its localization. Increasing
internalization of CCN2 was observed along with passing
of time, and CCN2 and LRP1 were partially co-localized
in HCS-2/8. Interestingly, the internalized rCCN2 was dis-
tributed in lysosomes, recycling endosomes and even in
the nucleus. To investigate the role of LRP1 in chondro-
cytes, we treated HCS-2/8 with LRP1 siRNA. Decrease in
aggrecan and col2a1 mRNA levels was observed by the
siRNA treatment.
These findings suggest that LRP1 plays important roles
in the cartilage biology, possibly by regulating the amounts,
localities and signals of CCN2 in chondrocytes.
Specific polyclonal antibodies against domains
of human CCN3 proteins
Noureddine Lazar, Nathalie Planque and Bernard Perbal
Laboratoire d`Oncologie Virale et Moléculaire, Université
Paris 7, D. Diderot, Paris, France
The CCN3 protein inhibits the growth and reduces the
tumorigenicity of a large variety of human cancer cell lines,
including glioblastoma choriocarcinoma and musculoskeletal
Ewing's sarcoma. The biological importance of truncated
isoforms in tumours was established by the identification of an
aminotruncated CCN3 protein expressed inMAV-induced
nephroblastoma.
The multimodular structure of the CCN3 and other CCN
proteins raises interesting questions as to participation of
each individual module conferring the biological properties
to the full length proteins. Either the biochemical functions
of the IGFBP, VWC, TPS, and CT modules contained these
proteins are indeed conserved and sum up in the full length
protein, or the presence of each module confers on the
whole protein specific biological function(s) which may
substitute or add upon those of individual modules.
In order to adress the biological functions of each
module, either individually or as part of CCN3, we
prepared highly specific polyclonal antibodies against each
CCN3 modules. Antibody purification was performed by
affinity chromatography. The antisera and immunopurified
antibodies detect the CCN3 protein expressed in mamma-
lian cells that produce CCN3 naturally or as the result of
transfection with expression vector encoding the full length
of ccn3 region. Cells transfected with plasmids encoding
aminotruncated CCN3 variants were also used in this study.
These new polyclonal antibodies should prove useful in
analyzing the structure-function relationships within CCN3.
Temporospatial localization of CCN5 protein
in murine and human embryos
Jennifer Malmquist, Maria Beatriz Oliveira, John Castellot
Department of Anatomy and Cell Biology, Tufts University
School of Medicine, Boston MA, USA
CCN5 is highly conserved among vertebrates and is the only
CCN family member lacking the C-terminal domain. CCN5
distribution in embryos has not been mapped in a systematic
manner. In the adult, CCN5 strongly inhibits smooth muscle
cell (SMC) proliferation and motility. The antiproliferative
action of CCN5 predicts that it should not be present in an
embryonic tissue until the proliferation phase of the mor-
phogenesis of that tissue is complete. To examine this hy-
pothesis, paraffin sections from murine embryos from 9–16
dpc and 4–5mo human embryos were analyzed by immu-
nohistochemistry using affinity-purified anti-peptide CCN5
antibodies. Surprisingly, CCN5 was present in nearly all
embryo tissues at the stages analyzed. While CCN5 protein
expression is initially present in most tissues, tissue-specific
expression increases as embryos age. Expression was
particularly strong in vascular tissues, cardiac muscle,
myotendonous junctions, intestinal smooth muscle and
epithelium, uterus, and bronchiolar epithelium. Expression
was absent in bone cartilaginous forms but increasingly
expressed as bones undergo ossification. The presence of
high levels of CCN5 in proliferating tissues suggests that it
functions in a cell-and tissue-specific context, and that the
presence of CCN5 is not sufficient by itself to prevent cell
proliferation.
NIH Grant HL49973 and NIH Grant HD046251
Promotion of adhesion and migration of human
bone marrow stromal cells by CCN2 –mechanism
and utility in bone regeneration-
Mitsuaki Ono1, Satoshi Kubota2, Takuo Fujisawa1,
Wataru Sonoyama1, Harumi Kawaki2, Kentaro Akiyama1,
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Masamitsu Oshima1, Takashi Nishida2, Masaharu Takigawa2,
Takuo Kuboki1
1Okayama University,Department of Oral and Maxillofacial
Rehabilitation and 2Okayama University, Dentistry and
Pharmaceutical Sciences
The bone marrow stem cells (BMSCs) are mainly composed
of mesenchymal stem cells that are potent in differentiating
into different cell types including osteoblasts. Here, we
investigated the effects of CCN2 on the adhesion and migra-
tion of human BMSC. For cell attachment assay, CCN2 was
adsorbed onto plastic or hydroxyapatite (HA) plate prior to
cell seeding. Activation of phophorylation signaling path-
way upon CCN2-mediated adhesion was also evaluated.
Migration of hBMSC was assessed by a modified Boyden
chamber method in vitro and with a porous HA/hBMSC
hybrid implanted subcutaneously in nude mice in vivo. As a
result, CCN2 significantly enhanced the hBMSC attach-
ment, which was neutralized by an anti-integrin αvβ3 anti-
body. Upon the adhesion mediated by CCN2, p38MAPK
was activated and the enhanced cell attachment by CCN2
was neutralized by a p38MAPK inhibitor. This enhancement
of cell adhesion was mainly mediated by the C-terminal
module of the CCN2. The migration of hBMSC was also
stimulated dramatically by CCN2. Moreover, in vivo eval-
uation indicated that CCN2 accelerated the hBMSC-like
cell migration and survival inside the porous HA. These
results strongly suggest the utility of CCN2 in the regen-
eration of an intractable bone defect in combination with
HA scaffold and BMSC.
CCN5-induced gene expression in uterine
smooth muscle
Joshua Russo, John Castellot
Department of Anatomy and Cell Biology, Tufts University
School of Medicine, Boston MA, USA
Smooth muscle cells (SMC) in the myometrium of the
uterus are involved in a number of uterine pathologies,
including leiomyoma (fibroids). Clinical presence of leio-
myomas in the general female population is 15–20%, and
the prevalence rises to > 60% in black women. To date, the
only treatment proven to prevent recurrence of the disease
is total abdominal hysterectomy, a procedure performed
over 600,0000 times annually in the United States alone.
The development of less drastic therapeutic alternatives
requires a detailed understanding of the cellular and
molecular mechanisms regulating both leiomyoma and
normal SMC. Earlier work in our laboratory has shown
that primary cultures of neoplastic SMC cells isolated from
fibroids display no endogenous production of CCN5
protein, while SMC derived from the myometrium of the
same patients display normal levels of CCN5. In addition,
forced expression of CCN5 utilizing an adenoviral system
inhibits the proliferation and motility of cultured leio-
myoma cells. Significantly, neither the upstream nor
downstream regulatory elements of CCN5’s biological
activities have been examined. The objective of the present
study is to use gene microarray technology supplemented
by quantitative PCR to determine potential candidates for
downstream effector molecules of CCN5 in uterine SMC.
Using an adenoviral infection system, CCN5 protein
production was upregulated in two patient samples of
cultured human uterine myometrial and leiomyoma cells.
RNA extracted from the cells was hybridized to a human
gene microarray slide containing 21,000 genes. Three
separate slides were analyzed for each sample and
compared; all displayed highly consistent changes. Prelim-
inary analysis indicates that a total of 505 genes (.024%)
display a 3-fold or greater change in the presence of
increased CCN5. Prominent among the CCN5-regulated
genes are a cluster of approximately 30 extracellular
matrix-associated genes. The CCN5-regulated proteins
include collagens, MMPs, integrins, and others. To validate
the microarray data, quantitative PCR was performed on a
number of the regulated genes. While specific interpreta-
tion of these results requires further analysis, the pattern
of regulated genes is consistent with the anti-proliferative
and anti-motility effects caused by CCN5 overexpression
and suggests that the ability of CCN5 to regulate a
relatively large group of extracellular matrix associated
genes represents an important role for this protein class in
mediating the mechanism of action of CCN5.
Supported by NIH Grant HD046251
WNT-induced secreted protein 1 (WISP1/CCN4)
mRNA splicing variants in normal
and transformed chondrocytes
Takeshi Yanagita1, Satoshi Kubota1, Kazumi Kawata1,
Harumi Kawaki1, Teruko Takano-Yamamoto2,
Shinji Tanaka3, Masaharu Takigawa1
1Department of Biochemistry and Molecular Dentistry,
Okayama University Graduate School of Medicine, Dentistry
and Pharmaceutical Sciences, Okayama, Japan and 2Department
of Orthodontics and Dentofacial Orthopedics, Okayama
University Graduate School of Medicine, Dentistry and
Pharmaceutical Sciences, Okayama, Japan, 3Department of
Hepato-Biliary-Panccreatic Surgery, Graduate School of
Medicine and Dentistry, Tokyo Medical and Dental University,
Tokyo, Japan
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WISP1/CCN4 is one of the CCN family proteins comprising
6 members. Several reports described a WISP1 variant
(WISP1v) lacking the VWC module in a few malignancies,
but no information concerning the production of WISP1
variants in normal tissue in currently available. In this
study, expression and processing of WISP1 mRNA was
analyzed in a human chondrosarcoma-derived cell line
(HCS-2/8), as well as in other cell lines of different
origins. Subsequently, expression of WISP1 mRNA along
normal chondrocyte differentiation was similarly analyzed,
using rabbit growth cartilage cells (RGC) that were cul-
tured and sampled following a long time course until they
were mineralized. Our results showed that WISP1,
WISP1v, and a novel variant of WISP1 (WISP1vx)
mRNA were expressed in the HCS-2/8 cells. This new
variant was lacking the VWC and TSP modules and a part
of IGFBP module. This finding suggests a possible role of
WISP1vx as well as WISP1v in malignant transformation
of chondrocytes. Moreover, we identified WISP1v ortho-
logue as well as that of the full-length mRNA in normal
RGC. Interestingly, overexpression of WISP1v in HCS-2/
8 cells enhanced the late chondrocytic phenotype of those
cells. These results suggest a critical role of WISP1v in
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